Works by Liu, Ta-Chih


Results: 54
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14

    Prenatal diagnosis of thalassemia in the Chinese.

    Published in:
    American Journal of Hematology, 1997, v. 55, n. 2, p. 65, doi. 10.1002/(SICI)1096-8652(199706)55:2<65::AID-AJH3>3.0.CO;2-0
    By:
    • Liu, Ta-Chih;
    • Lin, Sheng-Fung;
    • Yang, Tzu-Yao;
    • Lee, Jing-Ping;
    • Chen, Tyen-Po;
    • Chang, Jan-Gowth
    Publication type:
    Article
    15
    16
    17
    18
    19
    20
    21
    22
    23
    25
    26
    27

    An Open‐Label, Single‐Arm, Two‐Stage, Multicenter, Phase II Study to Evaluate the Efficacy of TLC388 and Genomic Analysis for Poorly Differentiated Neuroendocrine Carcinomas.

    Published in:
    Oncologist, 2020, v. 25, n. 5, p. e782, doi. 10.1634/theoncologist.2019-0490
    By:
    • Chen, Ming‐Huang;
    • Chou, Wen‐Chi;
    • Hsiao, Chin‐Fu;
    • Jiang, Shih Sheng;
    • Tsai, Hui‐Jen;
    • Liu, Yi‐Chang;
    • Hsu, Chiun;
    • Shan, Yan‐Shen;
    • Hung, Yi‐Ping;
    • Hsich, Chia‐Hsun;
    • Chiu, Chao‐Hua;
    • Liu, Ta‐Chih;
    • Cho, Shih‐Feng;
    • Liu, Tsang‐Wu;
    • Chao, Yee
    Publication type:
    Article
    28
    29
    30
    31
    32
    33

    Molecular basis of the A2B in Taiwan.

    Published in:
    2008
    By:
    • Chang, Chao-Sung;
    • Lin, Kuan-Tsao;
    • Chang, Jan-Gowth;
    • Lin, Chin-Wein;
    • Hsieh, Li-Ling;
    • Yeh, Chi-Jung;
    • Liu, Ta-Chih
    Publication type:
    journal article
    34
    35
    36
    37
    38
    39

    Satisfaction with pain management and impact of pain on quality of life in cancer patients.

    Published in:
    Asia Pacific Journal of Clinical Oncology, 2020, v. 16, n. 2, p. e91, doi. 10.1111/ajco.13095
    By:
    • Lin, Johnson;
    • Hsieh, Ruey‐Kuen;
    • Chen, Jen‐Shi;
    • Lee, Kuan‐Der;
    • Rau, Kun‐Ming;
    • Shao, Yu‐Yun;
    • Sung, Yung‐Chuan;
    • Yeh, Su‐Peng;
    • Chang, Cheng‐Shyong;
    • Liu, Ta‐Chih;
    • Wu, Ming‐Fang;
    • Lee, Ming‐Yang;
    • Yu, Ming‐Sun;
    • Yen, Chia‐Jui;
    • Lai, Pang‐Yu;
    • Hwang, Wen‐Li;
    • Chiou, Tzeon‐Jye
    Publication type:
    Article
    40
    41
    42
    43

    MDM2 promoter polymorphism and p53 codon 72 polymorphism in chronic myeloid leukemia: The association between MDM2 promoter genotype and disease susceptibility, age of onset, and blast-free survival in chronic phase patients receiving imatinib.

    Published in:
    Molecular Carcinogenesis, 2014, v. 53, n. 12, p. 951, doi. 10.1002/mc.22061
    By:
    • Liu, Yi‐Chang;
    • Hsiao, Hui‐Hua;
    • Yang, Wen‐Chi;
    • Liu, Ta‐Chih;
    • Chang, Chao‐Sung;
    • Yang, Ming‐Yu;
    • Lin, Pai‐Mei;
    • Hsu, Jui‐Feng;
    • Lee, Ching‐Ping;
    • Lin, Sheng‐Fung
    Publication type:
    Article
    44
    45
    46
    47
    48

    NOVEL-1st: an observational study to assess the safety and efficacy of nilotinib in newly diagnosed patients with Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase in Taiwan.

    Published in:
    International Journal of Hematology, 2022, v. 115, n. 5, p. 704, doi. 10.1007/s12185-022-03311-1
    By:
    • Hwang, Wen-Li;
    • Chen, Tsung-Chih;
    • Lin, Hsuan-Yu;
    • Chang, Ming-Chih;
    • Hsiao, Pei-Ching;
    • Bai, Li-Yuan;
    • Kuo, Ching-Yuan;
    • Chen, Yeu-Chin;
    • Liu, Ta-Chih;
    • Gau, Jyh-Pyng;
    • Wang, Po-Nan;
    • Hwang, Wei-Shou;
    • Kuo, Ming-Chung;
    • Liu, Chun-Yu;
    • Liu, Yi-Chang;
    • Ma, Ming-Chun;
    • Su, Nai-Wen;
    • Wang, Chuan-Cheng;
    • Wu, Yi-Ying;
    • Yao, Ming
    Publication type:
    Article
    49
    50